Stephen Thanks
I can see a possible conversation like this....Roger CEO Of PAB phones Amgen CEO....
Roger: Sorry to hear about you having to terminate advanced gastric cancer studies due to results. Unfortunate given all the work put in....but I may have an answer as to how you may progress this and build on work done with another drug which is at outlicencing stage with proven survival rates for gastric cancer...
Amgen CEO: I assume you are talking about PAT - SC1. Yes our board was just discussing this. Can we talk numbers and potentially progressing due diligence on PAT - SC1 as if numbers stack up we may be able to do something....
Roger: How would you like to progress this as PAT - SC1 is ready for out licencing and already talking to other parties but of course may make more sense to partner with Amgen given collaboration on PAT - SM6.
Amgen CEO: I I will have my people be in touch with your people....
Ann: Patrys 2014 AGM Presentation, page-54
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.002(33.3%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $95.25K | 26.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 29109964 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 19424458 | 8 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |